Jamjoom Pharmaceuticals Factory Company
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Saudi Arabia.
P/E ratio
17.3Investors pay 17.3 for every 1 of Jamjoom Pharmaceuticals Factory Company's yearly profit, higher than 79% of Healthcare companies in Saudi Arabia.
P/B ratio
4.43The share price is 4.43 times Jamjoom Pharmaceuticals Factory Company's book value per share, higher than 88% of Healthcare companies in Saudi Arabia.
Market cap
SAR 8.3 BThe total market value of all of Jamjoom Pharmaceuticals Factory Company's shares at today's price (share price × number of shares), larger than 71% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Return on equity (ROE)
27.0%Jamjoom Pharmaceuticals Factory Company earned 27.0% on its shareholders' money over the last year, higher than 77% of Healthcare companies in Saudi Arabia.
Dividend yield
3.46%Jamjoom Pharmaceuticals Factory Company pays 3.46% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in Saudi Arabia.
Questions
What is Jamjoom Pharmaceuticals Factory Company's P/E ratio?
Investors pay 17.3 for every 1 of Jamjoom Pharmaceuticals Factory Company's yearly profit, higher than 79% of Healthcare companies in Saudi Arabia.
What is Jamjoom Pharmaceuticals Factory Company's return on equity?
Jamjoom Pharmaceuticals Factory Company earned 27.0% on its shareholders' money over the last year, higher than 77% of Healthcare companies in Saudi Arabia.
Does Jamjoom Pharmaceuticals Factory Company pay a dividend?
Yes. Jamjoom Pharmaceuticals Factory Company pays 3.46% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in Saudi Arabia.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.